ASX:RAC
ASX:RACBiotechs

Are Race Oncology's (ASX:RAC) New Bisantrene Patents a Turning Point for Its Competitive Edge?

Earlier this week, Race Oncology announced a scientific discovery regarding the composition of the chemotherapy drug Bisantrene and has filed three patent applications based on these findings. This move highlights the company’s continued research efforts to strengthen its intellectual property protection in the oncology treatment space. We’ll explore how Race Oncology’s patent applications on new Bisantrene discoveries may influence its investment narrative and future opportunities. Find...
ASX:NHC
ASX:NHCOil and Gas

How Declining Dividends and Rising Output at New Hope (ASX:NHC) May Reshape Its Capital Strategy

New Hope Corporation Limited recently reported its full year 2025 results, announcing a final dividend of A$0.15 per share, a slight decrease in net income to A$439.37 million, and group coal production rising 18.1% to 10.7 Mt, all in line with guidance. While the company achieved higher production and met operational targets, the lower dividend and dip in earnings highlight the impact of market and regulatory challenges facing thermal coal producers. We’ll explore how meeting production...